CAR-T

CAR-T therapy
#Blood cancer #CAR-T #Cell therapy #Gilead Sciences #Kite Pharma #National Institute for Health and Care Excellence (NICE) #Oncology

UK’s NICE expands use of CAR-T cell therapy for blood cancer

The UK’s National Institute for Health and Care Excellence (NICE) has recommended additional uses for two CAR-T therapies from Gilead Sciences/Kite, as part of the Cancer Drugs Fund (CDF). Yescarta (axicabtagene ciloleucel: axi-cel) has been recommended by NICE for the treatment of eligible adult patients with diffuse large B cell… Read More

#News #Regulatory #Trending News

CAR-T cell
#CAR-T #Cell therapy #HIV #University of California

Researchers hope to cure HIV using CAR-T cells

University of California researchers have dosed the second participant in their clinical trial to identify a potential cure for HIV utilising CAR-T cell therapy. The first participant was dosed with anti-HIV duoCAR T cells at UC Davis Medical Center in mid-August. The trial is the first-in-human… Read More

#News

#Cancer research #CAR-T #Immunotherapy #Interview #Meet the Researcher #Oncology

Meet the researcher: John Maher, Leucid Bio

Listen to this article on the DDW Podcast: John Maher, Leucid Bio, tells Megan Thomas about his work and offers valuable advice to others in this field. MT: Where do you work, and can you tell us what you’re working on at the moment? JM: I am Chief Scientific Officer of a CAR… Read More

#Exclusive Content

#Breast cancer #Cancer research #CAR-T #Drug discovery #Immunotherapy #Oncology #Pancreatic cancer #Prostate cancer #Solid tumours

Latest episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week we have seen a number of developments in the treatment of solid tumours… Read More

#News

ACROBiosystems DDW white paper
#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #GMP

Diving deep into cell therapy: An industry perspective

Cell therapy research has never been more exciting with all of the research ongoing. Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell… Read More

#Resources

#Breast cancer #Cancer research #CAR-T #Drug discovery #Immunotherapy #Oncology #Pancreatic cancer #Prostate cancer #Solid tumours

This week in drug discovery (20-24 March)

News round-up for 20-24 March by DDW Digital Content Editor Diana Spencer.  This week we have seen a number of developments in the treatment of solid tumours hitting the headlines. Pennsylvania researchers may have found a way to boost CAR-T therapy in these tumours, previously only successful in… Read More

#News

CAR-T therapy
#Cancer research #CAR-T #Cell therapy #CRISPR #CRISPR-Cas9 #Gene editing #Oncology #Solid tumours

Double knockout strategy could boost CAR-T in solid tumours

A new approach that delivers a ‘one-two punch’ to help T cells attack solid tumours is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings showed that targeting two regulators that control gene functions… Read More

#Cancer Research #News #Trending News

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

New episode of the DDW Highlights podcast available

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As well as providing extensive coverage of the … Read More

#News

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

This week in drug discovery (27 February – 3 March)

News round-up for 27 February – 3 March by DDW Digital Content Editor Diana Spencer.  As well as providing extensive coverage of the SLAS2023 meeting in San Diego and Rare Disease Day, DDW has also reported on a… Read More

#News

CAR-T cell attacking cancer
#Cancer immunotherapy #Cancer research #CAR-T #Cell therapy #Immunotherapy #Karolinska Institutet #Oncology

CAR-T cell therapy holds promise for ovarian cancer

CAR-T cell therapy is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer.   The study authors, who work at Karolinska Institutet, hope that the discovery will pave the way for a clinical trial… Read More

#Cancer Research #News #Trending News

#Avacta #Cancer research #CAR-T #Cell therapy #Immunotherapy #Oncology #Precision medicine #T cell activation #Therapeutic targets

Precision cancer therapies: Where are we?

DDW’s Diana Spencer reports on the recent Avacta Therapeutics Science Day, which explored the latest exciting developments in precision and targeted treatments for cancer and asked what advances the future might bring. The Avacta Therapeutics Science Day brought together senior company scientists and international oncology experts to provide an overview… Read More

#Cancer Research #Exclusive Content

#Breast cancer #Cancer research #CAR-T #Drug development #Drug discovery #Immuno-oncology #Lung cancer #Oncology #World Cancer Day

The DDW Highlights Podcast: World Cancer Day 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As 4 February was World Cancer Day, this week’s update focused on… Read More

#News

#Breast cancer #Cancer research #CAR-T #Drug development #Drug discovery #Immuno-oncology #Lung cancer #Oncology #World Cancer Day

This week in drug discovery (30 January – 3 February)

News round-up for 30 January – 3 February by DDW Digital Content Editor Diana Spencer.  As February 4 is World Cancer Day, this week’s update focuses on developments in the field of oncology. Drugs for lung cancer, lymphoma and breast cancer have received regulatory approvals, an investment boost will … Read More

#News

Growing bacteria to create CAR therapy
#Cancer research #CAR-T #Immuno-oncology #Immunotherapy #Kite Pharma #National Institute for Health and Care Excellence (NICE) #NHS England #Oncology #UK

Ground-breaking CAR-T therapy approved in UK

Hundreds of people with an aggressive form of lymphoma are set to benefit from the first personalised immunotherapy treatment to be recommended for routine use in the NHS.  Axicabtagene ciloleucel (Yescarta, Kite) is a CAR-T therapy for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal… Read More

#News #Regulatory #Trending News

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

Keep up to date: DDW Highlights 30 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Cell and gene therapies have been making the news this week, as… Read More

#News